AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
Log in

NASDAQ:CTMXCytomX Therapeutics SEC Filings & 10K Form

$8.20
-0.21 (-2.50 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$8.11
Now: $8.20
$8.55
50-Day Range
$7.51
MA: $8.48
$9.42
52-Week Range
$3.60
Now: $8.20
$15.44
Volume396,000 shs
Average Volume568,468 shs
Market Capitalization$376.57 million
P/E RatioN/A
Dividend YieldN/A
Beta0.69

SEC Filings

CytomX Therapeutics (NASDAQ:CTMX) SEC Filings

DateFilerForm TypeView
06/19/2020
11:03 AM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
2:01 PM
CytomX Therapeutics (Issuer)
SCARLETT JOHN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:12 PM
CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:09 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:08 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:07 PM
CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:06 PM
CytomX Therapeutics (Issuer)
Fuchs Charles S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:54 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
4:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2020
5:49 PM
CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2020
5:48 PM
CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/28/2020
3:15 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2020
7:01 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
4:25 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2020
4:29 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G
02/27/2020
4:26 PM
CytomX Therapeutics (Filer)
Form 424B5
02/21/2020
11:34 AM
CytomX Therapeutics (Issuer)
Knifsend Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
4:20 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
5:41 PM
CytomX Therapeutics (Issuer)
Kavanaugh William Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:39 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:38 PM
CytomX Therapeutics (Issuer)
Peterson Amy C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:37 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
2:44 PM
CytomX Therapeutics (Issuer)
HANNAH ALISON L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
2:43 PM
CytomX Therapeutics (Issuer)
HANNAH ALISON L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2020
9:23 AM
CytomX Therapeutics (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G
01/27/2020
1:03 PM
CytomX Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
12/16/2019
3:20 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
3:11 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
6:01 PM
CytomX Therapeutics (Issuer)
Peterson Amy C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
5:59 PM
CytomX Therapeutics (Issuer)
Peterson Amy C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/29/2019
3:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2019
4:19 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2019
3:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
3:20 PM
CytomX Therapeutics (Filer)
Form 8-K/A
06/21/2019
3:14 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
1:06 PM
CytomX Therapeutics (Issuer)
SCARLETT JOHN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
1:05 PM
CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
1:04 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
1:03 PM
CytomX Therapeutics (Issuer)
Fuchs Charles S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
1:02 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
1:01 PM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:06 PM
CytomX Therapeutics (Issuer)
Knifsend Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
3:04 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:22 PM
CytomX Therapeutics (Issuer)
Knifsend Robin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2019
5:06 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
11:27 AM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4/A
05/09/2019
3:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:06 PM
CytomX Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
7:00 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
6:58 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/26/2019
2:49 PM
CytomX Therapeutics (Filer)
Form DEFA14A
04/26/2019
2:46 PM
CytomX Therapeutics (Filer)
Form DEF 14A
04/22/2019
3:16 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
7:52 PM
CytomX Therapeutics (Issuer)
GLUCK FREDERICK W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
9:34 AM
CytomX Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
04/08/2019
3:07 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2019
3:08 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2019
1:57 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
3:40 PM
CytomX Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2019
6:36 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
12:51 PM
CytomX Therapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G
02/13/2019
10:50 AM
CytomX Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/11/2019
11:15 PM
CytomX Therapeutics (Filer)
Form EFFECT
02/06/2019
3:39 PM
CytomX Therapeutics (Filer)
Form S-3/A
02/04/2019
9:07 AM
BlackRock Inc. (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G/A
01/31/2019
3:06 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2019
6:01 PM
CytomX Therapeutics (Issuer)
Kavanaugh William Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
6:00 PM
CytomX Therapeutics (Issuer)
HUMPHREY RACHEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
5:58 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
5:57 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
5:56 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
11:42 AM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2018
11:40 AM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2018
7:06 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2018
2:23 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
12:57 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
12:55 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
12:17 PM
CytomX Therapeutics (Filer)
Form CT ORDER
11/19/2018
11:59 AM
CytomX Therapeutics (Filer)
Form CT ORDER
11/06/2018
3:14 PM
CytomX Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/06/2018
3:07 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:02 PM
CytomX Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2018
3:15 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2018
3:14 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2018
6:30 AM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
2:18 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
6:18 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
6:14 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
3:02 PM
CytomX Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2018
7:55 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2018
3:10 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2018
3:09 PM
CytomX Therapeutics (Filer)
Form 424B5
07/10/2018
3:06 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2018
5:15 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2018
5:52 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
5:51 PM
CytomX Therapeutics (Issuer)
RAY DEBANJAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2018
5:50 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
4:52 PM
CytomX Therapeutics (Issuer)
Fuchs Charles S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
4:51 PM
CytomX Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
4:51 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.